Daily Current Affairs – 09-06-2025

Tamil Nadu

Indigenous Thrombectomy Device Development

® India to manufacture its first indigenously developed mechanical thrombectomy device for stroke care. ® Supported by the Technology Development Board (TDB). ® Developed by S3V Vascular Technologies, Mysuru. ® Integrated facility to be set up near Sriperumbudur, Tamil Nadu. ® Device treats ischaemic strokes by removing blood clots from brain vessels. ® India reported 1.25 million new stroke cases in 2021, a 51% rise since 1990.

BharatGen: India’s First Indigenous Multimodal LLM Launched

® Launched by Dr. Jitendra Singh at the BharatGen Summit, New Delhi ® Developed under NMICPS, led by IIT Bombay ® India’s first government-funded multimodal LLM, supporting 22 Indian languages ® Aims to transform healthcare, education, agriculture, and governance ® Promotes ethical, inclusive, and culturally relevant AI, aligned with PM’s vision of ‘India’s Techade’

India’s First AI SEZ to Be Set Up in Nava Raipur

® India’s first Artificial Intelligence Special Economic Zone (AI SEZ) to be developed in Nava Raipur, Chhattisgarh ® Project led by RackBank Datacenters Pvt. Ltd., with an investment of ₹ 1,000 crore ® Aims to build advanced infrastructure for AI research, development, and deployment ® Positions India as a global hub for AI innovation

mNexspike COVID-19 Vaccine Approved in the U.S.

® The U.S. has approved mNexspike, a next-generation COVID-19 vaccine developed by Moderna. ® It uses a lower dosage — one-fifth of the original Moderna COVID-19 vaccine dose. ® Target groups include individuals aged 65 and above, and those aged 12 to 64. ® The approval marks progress toward more efficient and advanced vaccine formulations for COVID-19.